Funder
French National Research Agency
Reference62 articles.
1. Gastroretentive technologies in tandem with controlled-release strategies: a potent answer to oral drug bioavailability and patient compliance implications;Vrettos;Pharmaceutics,2021
2. Riboflavin deficiency—implications for general human health and inborn errors of metabolism;Mosegaard;Int. J. Mol. Sci.,2020
3. Riboflavin,2011
4. Riboflavin dosage and recommendation, https://www.drugs.com/monograph/riboflavin.html.
5. Riboflavin metabolism: role in mitochondrial function;Balasubramaniam;J. Transl. Genet. Genomics,2020